EUVIMEDEUVIMED entdecken
Crossref

Individual HLAs affect survival after allogeneic stem cell transplantation in adult T‐cell leukaemia/lymphoma

Satoko Morishima, Makoto Yoshimitsu, Takero Shindo, Atae Utsunomiya, Takashi Ishida, Ayumu Ito, Nobuaki Nakano, Toshiro Kawakita, Tetsuya Eto, Youko Suehiro, Hidehiro Itonaga, Yasuo Mori und 10 weitere

HLA · 2024

DOI: 10.1111/tan.15555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Satoko Morishima und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, (Second Department of Internal Medicine), Graduate School of Medicin…. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Hematopoietic Stem Cell Transplantation, Transplantation, Homologous, HLA Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only curative therapy for adult T‐cell leukaemia/lymphoma (ATL). Specific HLAs are associated with outcomes of immunotherapy and allo‐HSCT. We hypothesised that individual HLAs would affect the clinical outcomes of ATL patients after allo‐HSCT. Using data from a Japanese registry, we retrospectively analysed 829 patients with ATL who received transplants from HLA‐identical sibling donors or HLA‐A, ‐B, ‐C or ‐DRB1 allele‐matched unrelated donors between 1996 and 2015. We evaluated the overall mortality risk of HLA‐A, ‐B and ‐DR antigens with frequencies exceeding 3%. Outcomes were compared between transplants with or without specific HLA antigens. Of the 25 HLAs, two candidates were identified but showed no statistically significant differences by multiple comparison. HLA‐B62 was associated with a lower risk of mortality (hazard ratio [HR], 0.68; 95% confidence interval [CI]: 0.51–0.90; p = 0.008), whereas HLA‐B60 was associated with a higher risk of mortality (HR, 1.64; 95% CI: 1.19–2.27; p = 0.003). In addition, HLA‐B62 was associated with a lower risk of transplant‐related mortality (TRM) (HR, 0.52; 95% CI: 0.32–0.85, p = 0.009), whereas HLA‐B60 was associated with a higher risk of grades III–IV acute graft‐versus‐host disease (HR, 2.63; 95% CI: 1.62–4.27; p < 0.001). Neither HLA influenced relapse. The higher risk of acute GVHD in HLA‐B60‐positive patients and the lower risk of TRM in HLA‐B62‐positive patients were consistent with previously obtained results from patients with other haematological malignancies. Consideration of HLA in ATL patients may help to predict risk and outcomes after allo‐HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia-Lymphoma, Adult T-CellHematopoietic Stem Cell TransplantationTransplantation, HomologousHLA AntigensGraft vs Host DiseaseHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAgedAllelesHistocompatibility TestingYoung AdultJapanRegistries

Stichwörter der Autor:innen

HLAadult T‐cell leukaemia/lymphomaallogeneic stem cell transplantationtransplant outcomes

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
  • Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
  • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Morishima, S., Yoshimitsu, M., Shindo, T., Utsunomiya, A., Ishida, T., Ito, A., Nakano, N., Kawakita, T., Eto, T., Suehiro, Y., Itonaga, H., Mori, Y., Miyazaki, Y., Kanda, J., Uchida, N., Sawayama, Y., Tomori, S., Ichinohe, T., Atsuta, Y., …, & ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy (2024). Individual HLAs affect survival after allogeneic stem cell transplantation in adult T‐cell leukaemia/lymphoma. HLA. https://doi.org/10.1111/tan.15555

Vancouver

Morishima S, Yoshimitsu M, Shindo T, Utsunomiya A, Ishida T, Ito A, et al. Individual HLAs affect survival after allogeneic stem cell transplantation in adult T‐cell leukaemia/lymphoma. HLA. 2024. doi:10.1111/tan.15555

BibTeX
@article{Morishima2024,
  author = {Morishima, Satoko and Yoshimitsu, Makoto and Shindo, Takero and Utsunomiya, Atae and Ishida, Takashi and Ito, Ayumu and Nakano, Nobuaki and Kawakita, Toshiro and Eto, Tetsuya and Suehiro, Youko and Itonaga, Hidehiro and Mori, Yasuo and Miyazaki, Yasuhiko and Kanda, Junya and Uchida, Naoyuki and Sawayama, Yasushi and Tomori, Shouhei and Ichinohe, Tatsuo and Atsuta, Yoshiko and Fukuda, Takahiro and Kato, Koji and ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy, ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy},
  title = {Individual HLAs affect survival after allogeneic stem cell transplantation in adult T‐cell leukaemia/lymphoma},
  journal = {HLA},
  year = {2024},
  doi = {10.1111/tan.15555}
}
Kostenlos starten →